Dihydromyricetin Protects against Diabetic Cardiomyopathy in Streptozotocin-Induced Diabetic Mice

Diabetic cardiomyopathy (DCM) is an important cause of heart failure in diabetic patients. The present study sought to explore the potential effects of dihydromyricetin (DHM) on DCM and its possible mechanism. A diabetic model was induced by intraperitoneal injection of streptozotocin (STZ) in C57BL...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Biomed Res Int
Autori principali: Wu, Bin, Lin, Jie, Luo, Jian, Han, Dong, Fan, Miaomiao, Guo, Tao, Tao, Ling, Yuan, Ming, Yi, Fu
Natura: Artigo
Lingua:Inglês
Pubblicazione: Hindawi 2017
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5379084/
https://ncbi.nlm.nih.gov/pubmed/28421194
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/3764370
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi